BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Shanghai Juncell Therapeutics readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Shanghai Juncell Therapeutics's d
 rugs run\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07560111-8738@assetmemo.bio
DTSTAMP:20261121T010438Z
DTSTART;VALUE=DATE:20270601
DTEND;VALUE=DATE:20270602
SUMMARY:GC101: Phase 2 readout est. (NCT07560111)
DESCRIPTION:GC101\, phase 2\, Non-Small Cell Lung Cancer.\nStudy: A Phase I
 I Study of GC101 in NSCLC\nEstimated primary completion: 1 June 2027. This
  is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it 
 can move.\nDrug page: https://assetmemo.bio/drug/gc101#upcoming-events\nRe
 gistry record: https://clinicaltrials.gov/study/NCT07560111
URL:https://assetmemo.bio/drug/gc101#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
